Private limited company · Bergen
DEEPX HEALTH AS
ActiveWholesale of pharmaceutical and medical goods (46.460)
The life line 2002–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 750k.
- Fullmakt kapitalforhøyelse§ 14
- Kapital§ 14
- Chair took office§ 07
- Managing director took office§ 07
- Founded§ 16
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
DEEPX HEALTH AS is a private limited company in Bergen, founded in 2002, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Christian Horn, and the chair of the board is Filip Truyen. In 2025 the company had NOK 750k in operating revenue and a net profit of NOK −4.7m. The largest owner is PLASMACUTE AS with 26.6%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 3 Aug 2026
- Fullmakt konvertibelt lån
- Fullmakt kapitalforhøyelse
- Konvertibelt lån
- Annual accounts filed 2024 → 2025
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- OKEquity ratio 85.7%, above the industry median
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 750k in 2025
Revenue
NOK 750k
−5.4% from 2024
20232025
Operating profit
NOK −1.0m
+32.5% from 2024
20232025
Net profit
NOK −4.7m
−106.9% from 2024
20232025
Equity
NOK 136.6m
−3.3% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 189%
- Other operating costs 49%
Costs exceeded revenue: the operating result was NOK −1.0m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 85.7%
- DEEPX HEALTH AS, 2025
- Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%
Equity NOK 136.6m86% of the assets (NOK 159.3m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.
Finances
§ 06 Accounts
24 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 750 | 793 | 132 | |
| Operating profit | −1,035 | −1,532 | −1,080 | |
| Profit before tax | −4,711 | 67,949 | −43,720 | |
| Net profit | −4,711 | 67,949 | −43,720 | |
| Total assets | 159,323 | 160,668 | 75,581 | |
| Equity | 136,567 | 141,279 | 58,486 | |
| Liabilities | 22,756 | 19,389 | 17,095 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 24 years →
Management and ownership
§ 07 Officers
6 officers now
- ERNST & YOUNG ASAuditor since 2002
- COMPLÉR ACCOUNTING ASAccountant
- Christian HornChief executive since 2002
- Filip TruyenChair of the board since 2019
- Christian HornBoard member since 2002
- Hans Johan HeklandBoard member since 2019
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 6 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
To styremedlemmer i fellesskap. Styrets leder alene.
May sign for the company:
To styremedlemmer i fellesskap. Styrets leder alene.
Procuration: none registered.
The board has 5 authorisations in force now: capital increase, until 30 Jun 2028; fullmakt konvertibelt lån, until 30 Jun 2028; fullmakt konvertibelt lån, until 30 Jun 2027; capital increase, until 30 Jun 2027; fullmakt konvertibelt lån, until 25 Nov 2026.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 24 Aug 2026
Management and ownership
§ 09 Owners
43 shareholders · largest 26.6%
| Owner | Share |
|---|---|
| PLASMACUTE AS | 26.6% |
| TJELTA AS | 16.6% |
| T.D. VEEN AS | 13.7% |
| 40 others | 43.1% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 43 owners →
Management and ownership
§ 10 Group
3 subsidiaries
- DEEPX ANALYTICS AS100%
- SCREENCANCER AS100%
- BALTER MEDICAL AS100%
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
Holds shares in 1 company
Source: the Tax Administration's Register of Shareholders, read 31 Jul 2026 · The whole portfolio →
Management and ownership
§ 12 Network
45 connections
- Person
- Company
3 people link DEEPX HEALTH AS to 35 other companies: Christian Horn 24, Hans Johan Hekland 12 and Filip Truyen 3.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
98 since 2015
Events per year
20152026
Since 2015: 182 announcements, 1 register change and 4 new and 1 former owners. Most happened in 2019 and 2020.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 98 events →
Events and registers
§ 14 Notices
182, latest 3 Aug 2026
- Fullmakt konvertibelt lån
- Fullmakt kapitalforhøyelse
- Konvertibelt lån
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 182 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 1 Jul 2002
- VATRegistered
- The Register of Business EnterprisesRegistered 1 Jul 2002
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Utvikling og salg/lisensiering av medisinske produkter og tjenester, og hva dermed står i naturlig forbindelse, herunder deltakelse i andre selskaper med lignende formål. Selskapet kan også investere i verdipapirer, enten i form av oppfølgingsinvesteringer i selskap man allerede har investert i, eller som ledd i andre strategiske investeringer.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 46.460
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
7 questions
- Who is the chief executive of DEEPX HEALTH AS?
Christian Horn, since 2002. § 07 - Who owns DEEPX HEALTH AS?
43 shareholders. The largest is PLASMACUTE AS with 26.6%, TJELTA AS with 16.6% and T.D. VEEN AS with 13.7%. § 09 - What was the revenue in 2025?
NOK 750k in the company. § 06 - Who can sign for DEEPX HEALTH AS?
To styremedlemmer i fellesskap. Styrets leder alene. § 08 - Who is the auditor?
ERNST & YOUNG AS, from 1 Jul 2002. § 07 - Where is DEEPX HEALTH AS based?
c/o Complér Accounting AS, Vestre Strømkaien 7, 5008 Bergen. - When was DEEPX HEALTH AS founded?
10 Jun 2002, registered in the Register of Business Enterprises 1 Jul 2002. § 16
The answers come from the sections linked to, with their sources.